Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Neto

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Medicina (Kaunas, Lithuania)|January 8, 2025
Obstetric Intensive Care Admissions and Neonatal Outcomes: 15 Years of Experience from a Single CenterFilipa Ramalho Rocha, Tiago Neto Gonçalves, Maria Inês Xavier-Ferreira, et al.
Drug Development Research|July 14, 2019
Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16-transgenic miceJoana M O Santos, Alexandra Moreira-Pais, Tiago Neto, et al.
Molecular Oncology|August 3, 2023
Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicitiesRui M Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Medicina (Kaunas, Lithuania)|January 8, 2025
Obstetric Intensive Care Admissions and Neonatal Outcomes: 15 Years of Experience from a Single CenterFilipa Ramalho Rocha, Tiago Neto Gonçalves, Maria Inês Xavier-Ferreira, et al.
Drug Development Research|July 14, 2019
Dimethylaminoparthenolide reduces the incidence of dysplasia and ameliorates a wasting syndrome in HPV16-transgenic miceJoana M O Santos, Alexandra Moreira-Pais, Tiago Neto, et al.
Molecular Oncology|August 3, 2023
Pharmacological NF-κB inhibition decreases cisplatin chemoresistance in muscle-invasive bladder cancer and reduces cisplatin-induced toxicitiesRui M Gil da Costa, Christine Levesque, Daniella Bianchi-Frias, et al.
Pageof 4